Log in to save to my catalogue

Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disea...

Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7196249

Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disease in prostate cancer patients: an asian population-based observational study

About this item

Full title

Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disease in prostate cancer patients: an asian population-based observational study

Publisher

Australia: Ivyspring International Publisher Pty Ltd

Journal title

Journal of Cancer, 2020-01, Vol.11 (14), p.4015-4022

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher Pty Ltd

More information

Scope and Contents

Contents

: To conduct a population-based study to determine whether the use of GnRH agonist and antiandrogens are associated with an increased risk of cardio-cerebrovascular disease (CCVD) in Asian patients with prostate cancer using the National Health Insurance Service-Elderly Cohort Database (NHIS-ECD).
: We included a total of 2,413 men aged 60 years...

Alternative Titles

Full title

Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disease in prostate cancer patients: an asian population-based observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7196249

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7196249

Other Identifiers

ISSN

1837-9664

E-ISSN

1837-9664

DOI

10.7150/jca.38237

How to access this item